Annual Total Expenses
$83.89 M
-$35.84 M-29.93%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total expenses is $83.89 million, with the most recent change of -$35.84 million (-29.93%) on June 30, 2024.
- During the last 3 years, AYTU annual total expenses has fallen by -$19.98 million (-19.24%).
- AYTU annual total expenses is now -36.82% below its all-time high of $132.77 million, reached on June 30, 2022.
Performance
AYTU Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$16.72 M
-$2.79 M-14.28%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total expenses is $16.72 million, with the most recent change of -$2.79 million (-14.28%) on September 30, 2024.
- Over the past year, AYTU quarterly total expenses has dropped by -$1.96 million (-10.51%).
- AYTU quarterly total expenses is now -57.06% below its all-time high of $38.93 million, reached on June 30, 2021.
Performance
AYTU Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AYTU Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.9% | -10.5% |
| 3 y3 years | -19.2% | -44.5% |
| 5 y5 years | +247.1% | -41.4% |
AYTU Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | at low | -51.6% | at low |
| 5 y | 5-year | -36.8% | +247.1% | -57.1% | +105.3% |
| alltime | all time | -36.8% | >+9999.0% | -57.1% | >+9999.0% |
Aytu BioPharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.72 M(-14.3%) |
| Jun 2024 | $83.89 M(-29.9%) | $19.50 M(-3.5%) |
| Mar 2024 | - | $20.21 M(-1.7%) |
| Dec 2023 | - | $20.57 M(+10.1%) |
| Sep 2023 | - | $18.68 M(-33.1%) |
| Jun 2023 | $119.73 M(-9.8%) | $27.92 M(-12.8%) |
| Mar 2023 | - | $32.02 M(+5.1%) |
| Dec 2022 | - | $30.47 M(+4.0%) |
| Sep 2022 | - | $29.31 M(-15.2%) |
| Jun 2022 | $132.77 M(+27.8%) | $34.55 M(+2.7%) |
| Mar 2022 | - | $33.66 M(-2.2%) |
| Dec 2021 | - | $34.42 M(+14.2%) |
| Sep 2021 | - | $30.14 M(-22.6%) |
| Jun 2021 | $103.87 M(+128.0%) | $38.93 M(+36.6%) |
| Mar 2021 | - | $28.51 M(+46.9%) |
| Dec 2020 | - | $19.41 M(+13.7%) |
| Sep 2020 | - | $17.08 M(-14.4%) |
| Jun 2020 | $45.55 M(+88.5%) | $19.96 M(+57.9%) |
| Mar 2020 | - | $12.64 M(+55.2%) |
| Dec 2019 | - | $8.14 M(+31.9%) |
| Sep 2019 | - | $6.18 M(-1.9%) |
| Jun 2019 | $24.17 M(+12.4%) | $6.30 M(-5.7%) |
| Mar 2019 | - | $6.68 M(+5.2%) |
| Dec 2018 | - | $6.35 M(+30.9%) |
| Sep 2018 | - | $4.85 M(+2.0%) |
| Jun 2018 | $21.50 M(-2.6%) | $4.75 M(-24.3%) |
| Mar 2018 | - | $6.28 M(+24.4%) |
| Dec 2017 | - | $5.04 M(-7.1%) |
| Sep 2017 | - | $5.43 M(+16.3%) |
| Jun 2017 | $22.08 M(+31.7%) | $4.67 M(-18.8%) |
| Mar 2017 | - | $5.75 M(+15.2%) |
| Dec 2016 | - | $4.99 M(-25.1%) |
| Sep 2016 | - | $6.67 M(-1.1%) |
| Jun 2016 | $16.77 M(+112.4%) | $6.74 M(+72.9%) |
| Mar 2016 | - | $3.90 M(+11.9%) |
| Dec 2015 | - | $3.48 M(+31.4%) |
| Sep 2015 | - | $2.65 M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | $7.89 M(>+9900.0%) | $2.33 M(+27.5%) |
| Mar 2015 | - | $1.83 M(>+9900.0%) |
| Feb 2015 | - | $9400.00(-38.6%) |
| Nov 2014 | - | $15.30 K(+41.7%) |
| Aug 2014 | $58.50 K(-99.1%) | $10.80 K(-10.7%) |
| Jun 2014 | $6.41 M(>+9900.0%) | - |
| May 2014 | - | $12.10 K(-41.3%) |
| Feb 2014 | - | $20.60 K(+37.3%) |
| Nov 2013 | - | $15.00 K(+64.8%) |
| Aug 2013 | $54.20 K(-6.7%) | $9100.00(-33.6%) |
| May 2013 | - | $13.70 K(+8.7%) |
| Feb 2013 | - | $12.60 K(-33.0%) |
| Nov 2012 | - | $18.80 K(-0.5%) |
| Aug 2012 | $58.10 K(-56.5%) | $18.90 K(+70.3%) |
| May 2012 | - | $11.10 K(+20.7%) |
| Feb 2012 | - | $9200.00(-51.3%) |
| Nov 2011 | - | $18.90 K(-73.3%) |
| Aug 2011 | $133.60 K(+135.6%) | $70.70 K(+253.5%) |
| May 2011 | - | $20.00 K(-24.0%) |
| Feb 2011 | - | $26.30 K(+58.4%) |
| Nov 2010 | - | $16.60 K(+26.7%) |
| Aug 2010 | $56.70 K(-1.6%) | $13.10 K(-5.1%) |
| May 2010 | - | $13.80 K(+22.1%) |
| Feb 2010 | - | $11.30 K(-38.9%) |
| Nov 2009 | - | $18.50 K(+77.9%) |
| Aug 2009 | $57.60 K(+4.7%) | $10.40 K(-1.0%) |
| May 2009 | - | $10.50 K(-30.5%) |
| Feb 2009 | - | $15.10 K(-29.8%) |
| Nov 2008 | - | $21.50 K(+82.2%) |
| Aug 2008 | $55.00 K(+17.3%) | $11.80 K(-31.8%) |
| May 2008 | - | $17.30 K(+63.2%) |
| Feb 2008 | - | $10.60 K(-30.3%) |
| Nov 2007 | - | $15.20 K(+35.7%) |
| Aug 2007 | $46.90 K | $11.20 K(-18.2%) |
| May 2007 | - | $13.70 K(-8.7%) |
| Feb 2007 | - | $15.00 K(+114.3%) |
| Nov 2006 | - | $7000.00(+268.4%) |
| May 2006 | - | $1900.00 |
FAQ
- What is Aytu BioPharma annual total expenses?
- What is the all time high annual total expenses for Aytu BioPharma?
- What is Aytu BioPharma annual total expenses year-on-year change?
- What is Aytu BioPharma quarterly total expenses?
- What is the all time high quarterly total expenses for Aytu BioPharma?
- What is Aytu BioPharma quarterly total expenses year-on-year change?
What is Aytu BioPharma annual total expenses?
The current annual total expenses of AYTU is $83.89 M
What is the all time high annual total expenses for Aytu BioPharma?
Aytu BioPharma all-time high annual total expenses is $132.77 M
What is Aytu BioPharma annual total expenses year-on-year change?
Over the past year, AYTU annual total expenses has changed by -$35.84 M (-29.93%)
What is Aytu BioPharma quarterly total expenses?
The current quarterly total expenses of AYTU is $16.72 M
What is the all time high quarterly total expenses for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total expenses is $38.93 M
What is Aytu BioPharma quarterly total expenses year-on-year change?
Over the past year, AYTU quarterly total expenses has changed by -$1.96 M (-10.51%)